TNRC6C and thyroiditis: In this study, targeted inhibition of TNRC6C-AS1 with shRNA decreased cell proliferation, migration, and invasion in ATC cell lines through downregulation of UNC5B expression and inhibited thyroid tumorigenesis in vivo.